End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
36.15
CNY
|
-2.95%
|
|
+8.23%
|
+0.72%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,264
|
3,711
|
3,983
|
Enterprise Value (EV)
1 |
2,769
|
3,228
|
3,743
|
P/E ratio
|
38.9
x
|
31.7
x
|
24.7
x
|
Yield
|
0.61%
|
0.9%
|
0.92%
|
Capitalization / Revenue
|
8.27
x
|
6.81
x
|
5.86
x
|
EV / Revenue
|
7.02
x
|
5.92
x
|
5.51
x
|
EV / EBITDA
|
24.9
x
|
20.1
x
|
16.6
x
|
EV / FCF
|
-36.9
x
|
-87.7
x
|
340
x
|
FCF Yield
|
-2.71%
|
-1.14%
|
0.29%
|
Price to Book
|
3.14
x
|
3.09
x
|
3.05
x
|
Nbr of stocks (in thousands)
|
113,471
|
110,989
|
110,989
|
Reference price
2 |
28.76
|
33.44
|
35.89
|
Announcement Date
|
3/30/22
|
4/3/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
266.7
|
300.7
|
286.9
|
394.7
|
545.1
|
679.4
|
EBITDA
1 |
104.7
|
104.6
|
91.92
|
111.2
|
160.6
|
225.3
|
EBIT
1 |
71.12
|
77.67
|
64.59
|
75.75
|
116.9
|
177.3
|
Operating Margin
|
26.67%
|
25.83%
|
22.51%
|
19.19%
|
21.45%
|
26.09%
|
Earnings before Tax (EBT)
1 |
77.25
|
85.86
|
69.88
|
96.77
|
136
|
198.4
|
Net income
1 |
66.98
|
74.65
|
60.25
|
80.06
|
118
|
163.6
|
Net margin
|
25.12%
|
24.83%
|
21%
|
20.28%
|
21.66%
|
24.07%
|
EPS
2 |
0.8059
|
0.8994
|
0.7259
|
0.7388
|
1.055
|
1.452
|
Free Cash Flow
1 |
29.47
|
-48.47
|
-59.14
|
-75.11
|
-36.82
|
11
|
FCF margin
|
11.05%
|
-16.12%
|
-20.61%
|
-19.03%
|
-6.75%
|
1.62%
|
FCF Conversion (EBITDA)
|
28.14%
|
-
|
-
|
-
|
-
|
4.88%
|
FCF Conversion (Net income)
|
44%
|
-
|
-
|
-
|
-
|
6.73%
|
Dividend per Share
2 |
0.1765
|
-
|
0.1765
|
0.1765
|
0.3000
|
0.3300
|
Announcement Date
|
6/21/19
|
9/3/20
|
4/27/21
|
3/30/22
|
4/3/23
|
3/29/24
|
Fiscal Period: December |
2023 Q3
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
51.13
|
Net margin
|
-
|
EPS
2 |
0.4540
|
Dividend per Share
|
-
|
Announcement Date
|
11/23/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
127
|
87.4
|
88.2
|
495
|
484
|
240
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
29.5
|
-48.5
|
-59.1
|
-75.1
|
-36.8
|
11
|
ROE (net income / shareholders' equity)
|
25.1%
|
23.1%
|
15.7%
|
11.1%
|
10.8%
|
13.6%
|
ROA (Net income/ Total Assets)
|
14.2%
|
12.9%
|
8.98%
|
5.19%
|
5.21%
|
6.12%
|
Assets
1 |
471.9
|
578.5
|
670.6
|
1,542
|
2,264
|
2,671
|
Book Value Per Share
2 |
3.530
|
4.250
|
4.980
|
9.170
|
10.80
|
11.80
|
Cash Flow per Share
2 |
1.550
|
1.050
|
1.060
|
3.690
|
4.120
|
3.160
|
Capex
1 |
37.8
|
110
|
123
|
152
|
154
|
131
|
Capex / Sales
|
14.19%
|
36.61%
|
42.73%
|
38.48%
|
28.31%
|
19.27%
|
Announcement Date
|
6/21/19
|
9/3/20
|
4/27/21
|
3/30/22
|
4/3/23
|
3/29/24
|
|
1st Jan change
|
Capi.
|
---|
| +0.72% | 552M | | 0.00% | 6.8B | | -12.39% | 2.88B | | -11.15% | 2.72B | | -31.21% | 1.74B | | +5.00% | 1.25B | | -7.31% | 1.06B | | -6.67% | 870M | | -4.08% | 794M | | -13.72% | 768M |
Testing Laboratories
|